Navigation Links
Hill-Rom Announces Fourth Quarter 2012 Dividend
Date:9/4/2012

BATESVILLE, Ind., Sept. 4, 2012 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its board of directors has declared a fiscal year 2012 fourth quarter dividend of $0.125 per share. This dividend is payable on September 28, 2012 to shareholders of record as of the close of business on September 14, 2012.

ABOUT HILL-ROM HOLDINGS, INC.
Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom…enhancing outcomes for patients and their caregivers.

www.hill-rom.com


'/>"/>
SOURCE Hill-Rom Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
2. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
3. Hill-Rom Reports Fiscal Third Quarter Results; Announces Aspen Surgical Acquisition; Lowers Full Year Financial Outlook
4. Hill-Rom Acquires Aspen Surgical Products
5. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Third Quarter Earnings Conference Call and Webcast
6. Hill-Rom Appoints Alton Shader President of Hill-Rom North America
7. Hill-Rom to Participate in the Bank of America Merrill Lynch 2012 Health Care Conference
8. Hill-Rom Announces Third Quarter 2012 Dividend
9. Hill-Rom to Participate in the Deutsche Bank Securities Health Care Conference
10. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
11. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 Eisai Inc. announced today that regulatory ... States , European Union and Japan ... for eribulin, for the treatment of patients with inoperable ... for advanced or metastatic disease. These ... global Phase 3 clinical trial (Study 309), which met ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, Inc. ... second Phase III clinical study for Ozenoxacin, a ... Medimetriks owns the exclusive U.S. rights to Ozenoxacin ... conducted at 44 centers with an emphasis on ... aged 2 months and older with a clinical ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... Cardiovascular Safety and Potential Benefits of Exenatide to be Prospectively ... June 8 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... ) today announced results from a meta-analysis of cardiovascular (CV) ... with BYETTA(R) (exenatide) injection use compared to a pooled comparator ...
... Dose Optimization of Pre-Clinical Otelixizumab Surrogate , ... a biopharmaceutical company engaged in the discovery and ... presented results from a pre-clinical dose-optimization study conducted ... monoclonal antibody, otelixizumab, at the 69th Scientific Sessions ...
Cached Medicine Technology:Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 2Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 3Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 4Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 5Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 6Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 3
(Date:7/31/2015)... ... July 31, 2015 , ... Healthpointe , a ... redesigned website at Healthpointe.net. The new website will feature a sleek and streamlined ... serves to provide smoother interactions between patients and the Healthpointe clinics and ensures ...
(Date:7/31/2015)... ... ... Physical therapy for knee osteoarthritis is an important part of knee pain ... from doing what they want or need to do. The patient may have trouble getting ... patient's exercise regime may be limited by the pain in their knee. When a patient ...
(Date:7/31/2015)... ... July 31, 2015 , ... An article entitled " Dentists ... a woman’s unfortunate experience having cosmetic skin procedures done by a family doctor ... blistering, swelling, bruising, and pain. This woman’s experience is only one in a ...
(Date:7/31/2015)... ... , ... Easter Seals Southern Georgia’s Heels & Wheels Duathlon & Triathlon will be held Saturday, ... AM. The duathlon is a 2 mile run, 13 mile bike ride, and a 3 ... mile bike, and a 3 mile run. Heels & Wheels is sponsored by Mayo ...
(Date:7/31/2015)... ... July 31, 2015 , ... With the recent buzz surrounding ... who remain undiagnosed, treatment options for patients are becoming more prevalent than ever ... due to its overall lack of comfort and highly invasive nature, oral appliances ...
Breaking Medicine News(10 mins):Health News:Healthpointe Announces Newly Redesigned Website 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2
... Illinois, US, have developed the next generation of self ... time after time . ,According to Nancy ... and the corresponding author of a paper detailing the ... networks that emulate biological circulatory systems. ,In ...
... be releasing dangerous levels of radioactive tritium . ... of tritium are 10 times higher than the United States ... precautionary measure the Green has said that children under the ... miles of a nuclear power station and those living within ...
... succeeded in drastically reducing anonymous and undocumented gun sales ... to gun shows reveals a study in the ... shows in California and 20 shows in Arizona, Nevada, ... outside sources for guns used in crime in California. ...
... star Keira Knightley is suffering from eating disorder anorexia . ... disorder started doing the rounds earlier this year when she ... befriended with Knightley on the sets of their latest film ... fellow co-star's health is perfectly sound. ,"She eats ...
... they stop smoking, says a new study, contradicting the ... . ,The new finding is the first to ... inflammation, it will continue even after they quit smoking. ... researchers in respiratory medicine including New Zealand Massey University ...
... 13 percent of waterfowls in Vietnam have bird flu ... ,Tests show that nearly 21.7 percent of waterfowls in ... over 7.6 percent in Bac Giang carry the virus, ... saying. ,To prevent the disease from spreading, ...
Cached Medicine News:Health News:Researchers Develop Material That Self Heals Like Human Skin 2Health News:Tritium Risks at New Heights 2Health News:Tougher Gun Show Controls in California Slash Sales of Weapons Linked to Crime 2
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
MBS 0.2 ml satellite block unit with height adjusting heated lid, 96 well standard block - holds 96 x 0.2ml tubes or 1 x 96 well plate (includes tube thermistor)...
PxE thermal Cycler. 0.2ml, 96 well block holds 96 tubes or 1 x 96 well plate. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User f...
... (PxE) is a licensed 96 well PCR machine, ... for money thermal cycling. It is built ... in manufacturing and retains a high level of ... products in the range. The combination of ...
Medicine Products: